FDA Approves Long-Acting Schizophrenia Treatment
Ryan Marotta, Assistant Editor
The FDA has approved Alkermes’ extended-release aripiprazole lauroxil injection (Aristada) for the treatment of schizophrenia in adults.
Krystle Vermes
The FDA has accepted Sandoz’s Biologics License Application (BLA) for its proposed etanercept (Enbrel) biosimilar.
Jeannette Y. Wick, RPh, MBA, FASCP
While flu vaccine effectiveness is traditionally measured across medically attended influenza patients, health care professionals can benefit from learning how the vaccine works in patients who don’t seek treatment.
Allison Gilchrist, Associate Editor
Pharmacists can lead by example by promoting the FDA’s patient safety initiatives in their practice settings.
Allison Gilchrist, Associate Editor
The historic Trans-Pacific Partnership negotiations finalized today could affect the cost of health care in significant ways.
Rachel Lutz
Medication dispensing within the first few months of prescribing chronic therapy can precisely predict future patient adherence.
Krystle Vermes
Sanofi has launched a generic version of the rheumatoid arthritis (RA) drug leflunomide (Arava).
Allison Gilchrist, Associate Editor
Side effects may vary, and occasionally take an odd turn.

Association News

The Generic Pharmaceutical Association and its Biosimilars Council strongly support efforts to improve worldwide patient access to affordable medicines.
The Pharmacy Technician Certification Board has become an official observer organization at the International Pharmaceutical Federation.
The first ever international overview of the extent of the advanced and specialised roles that pharmacists are undertaking, and the mechanisms supporting these developments, was presented at the World Congress of Pharmacy and Pharmaceutical Sciences today.
APhA supports the new initiative announced by the Centers for Medicare & Medicaid Services to improve the medication therapy management benefit for patients in stand-alone Medicare Part D plans.
The International Pharmaceutical Federation (FIP) this week awarded former ASHP CEO Henri R. Manasse, Jr., Ph.D., Sc.D., with the Joseph A. Oddis Award for Exceptional Service to FIP at the opening ceremony of the 75th World Congress of Pharmacy and Pharmaceutical Sciences in Düsseldorf, Germany.

Pharmacy Market News

Allergan has announced a multi-year research collaboration with Humana to explore new ideas and ways to improve the health and well-being of patients, members and their caregivers.
Vernalis Therapeutics has acquired the U.S. rights to Pragma Pharmaceuticals’ Moxatag (amoxicillin) extended-release tablets.
Teva has entered into definitive agreements under which it will acquire Representaciones e Investigaciones Médicas, S.A. de C.V. (Rimsa), a leading pharmaceutical manufacturing and distribution company in Mexico.

Strategic Alliance Partner News

The Meijer Simply Give campaign held this fall generated more than $3 million for food pantries throughout the Midwest, making it the most successful campaign in the program’s history.
CVS Health will be opening Hearing Centers in seven CVS/pharmacy stores in the Dallas and Cleveland markets and will be providing optical services in five store locations around the Baltimore and Washington, D.C., markets.
Latest Issues